3 - Wild Rose A - Oncology

12:15 PMCarissa Ganihong, Thomas Jefferson University HospitalEvaluating the Impact of a Clinical Pharmacist in Patients Receiving New Chemotherapy for Breast Cancer: Analysis of a Pilot Study
12:30 PMWilliam Raley, Hospital of the University of PennsylvaniaCauses of Discontinuation and Treatment Duration of Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
12:45 PMUmesh Yogarajah , The University of Vermont Medical CenterThe impact of antibiotic use on the clinical response of patients receiving immune checkpoint inhibitors
1:00 PMTonya Wright, MedStar Washington Hospital CenterEvaluation of the Safety of the New Alcohol Containing Cyclophosphamide Formulation
1:15 PMNatalie So, Medstar Montgomery Medical CenterEvaluation of fixed-dose versus body surface area-based leucovorin dosing in patients with colorectal cancer within a large health system
1:30 PMRachel Hartman, Hospital of the University of PennsylvaniaLevofloxacin prophylaxis for myeloablative allogeneic hematopoietic cell transplant
1:45 PMHalley Vess, Virginia Hospital CenterEvaluation of Appropriate Antibiotic Therapy in Febrile Neutropenic Patients Based on Order-Set Utilization in a Community Hospital Setting
2:00 PMSerena Mitaly, MedStar Washington Hospital CenterEvaluation of Angiotensin-Converting Enzyme Inhibitors and/or Beta-Blockers in Primary Prevention of Cardiac Dysfunction Caused by Anthracyclines and Trastuzumab in African American Breast Cancer Patients

Carissa Ganihong

William Raley

Umesh Yogarajah

Tonya Wright

Natalie So

Rachel Hartman

Halley Vess

Serena Mitaly

Bernadette Wolford (Moderator)

Racquel Reese-Leftridge (Moderator)

Key:

Complete
Failed
Available
Locked
3 - Wild Rose A - Oncology
05/17/2022 at 12:15 PM (EDT)  |  120 minutes
05/17/2022 at 12:15 PM (EDT)  |  120 minutes